Skip to main content

Imaging

1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Radiopharm Theranostics
Radiopharm TheranosticsAustralia - Carlton South
1 program
1
LNTH-2403Phase 11 trial
Active Trials
NCT07272642Not Yet Recruiting16Est. Oct 2027

Trial Timeline

Clinical trial activity over time

2026
2027
Radiopharm TheranosticsLNTH-2403

Clinical Trials (1)

Total enrollment: 16 patients across 1 trials

A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.

Start: Jan 2026Est. completion: Oct 202716 patients
Phase 1Not Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.